Evidence map›Paper›PMID 38551715›Full record

SynthesisEuropean journal of epidemiology2024

Prevalence of functional disorders across Europe: a systematic review and meta-analysis.

Caroline Rometsch, Giovanni Mansueto, Frederic Maas Genannt Bermpohl, Alexandra Martin, Fiammetta Cosci

Open access · hybridAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in European journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Caroline RometschDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 3, 50134, Florence, Italy. Carolina.Rometsch@unifi.it.ORCID http://orcid.org/0000-0002-3172-0823
Giovanni MansuetoDepartment of Health Sciences, University of Florence, Florence, Italy.
Frederic Maas Genannt BermpohlSchool of Human and Social Sciences, University of Wuppertal, Wuppertal, Germany.ORCID http://orcid.org/0000-0002-2370-4946
Alexandra MartinSchool of Human and Social Sciences, University of Wuppertal, Wuppertal, Germany.ORCID http://orcid.org/0000-0002-4235-8591
Fiammetta CosciDepartment of Health Sciences, University of Florence, Florence, Italy.ORCID http://orcid.org/0000-0002-5022-0488
University of Wuppertal · DEMaastricht University · NLSigmund Freud Privatuniversität - Standort Mailand · ITUniversity of Florence · IT

Funding

H2020 European Research Council 956673H2020 Marie Skłodowska-Curie Actions 956673
6 · The paper itself

Abstract

Functional Disorders (FD) refer to persistent somatic symptoms caused by changes in the functioning of bodily processes. Previous findings suggest that FD are highly prevalent, but overall prevalence rates for FD in European countries are scarce. Therefore, the aim of the present work was to estimate the point prevalence of FD in adult general populations. PubMed and Web of Science were searched from inception to June 2022. A generalized linear mixed-effects model for statistical aggregation was used for statistical analyses. A standardized quality assessment was performed, and PRISMA guidelines were followed. A total of 136 studies were included and systematically synthesized resulting in 8 FD diagnoses. The large majority of studies was conducted in the Northern Europe, Spain, and Italy. The overall point prevalence for FD was 8.78% (95% CI from 7.61 to 10.10%) across Europe, with the highest overall point prevalence in Norway (17.68%, 95% CI from 9.56 to 30.38%) and the lowest in Denmark (3.68%, 95% CI from 2.08 to 6.43%). Overall point prevalence rates for specific FD diagnoses resulted in 20.27% (95% CI from 16.51 to 24.63%) for chronic pain, 9.08% (95% CI from 7.31 to 11.22%) for irritable bowel syndrome, and 8.45% (95% CI from 5.40 to 12.97%) for chronic widespread pain. FD are highly prevalent across Europe, which is in line with data worldwide. Rates implicate the need to set priorities to ensure adequate diagnosis and care paths to FD patients by care givers and policy makers.

Indexed as

Irritable Bowel SyndromeChronic PainEuropeHumansPrevalenceEpidemiologyFunctional disordersMeta-analysisPrevalenceReview

Identifiers

PMID38551715
PMCPMC11249491
OpenAlexW4393316911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.